Lariam, also known by its generic name Mefloquine, is a widely recognized medication primarily used to prevent and treat malaria, a potentially life-threatening disease transmitted through mosquito bites in regions where the disease is prevalent. This medication belongs to the class of drugs called antimalarials, specifically categorized as a 4-quinoline compound. Lariam is highly effective in preventing malaria caused by Plasmodium falciparum and Plasmodium vivax, two of the most common malaria-causing parasites.
Mefloquine works by targeting the malaria parasites inside the body, preventing their growth and multiplication. This ultimately reduces the severity and duration of malaria symptoms if contracted. Additionally, Lariam is often prescribed to travelers visiting malaria-endemic regions, military personnel stationed in such areas, and individuals who live in or travel to regions with a high risk of malaria transmission.
One of the advantages of Lariam is its long-lasting effect, which makes it a convenient choice for travelers. It typically needs to be taken only once a week, starting one to two weeks before entering a malaria-prone area, continuing during the stay, and for four weeks after leaving the area. This dosing regimen can vary depending on individual circumstances, so it is essential to consult with a healthcare professional for precise guidance.
Lariam is generally well-tolerated, but like any medication, it may have potential side effects and contraindications.